TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.

Silencing TNFR1 on tumor cells reduces immune escape by decreasing MDSC recruitment, impairing tumor growth in immunocompetent hosts.

• Why it matters: Understanding how tumors evade immune responses is crucial for developing effective therapies, as immune suppression limits treatment success in many cancers.
• What they did: The study used CRISPR/Cas9 to knock out TNFR1 in tumor cells and analyzed tumor engraftment, immune cell infiltration, and secondary inflammatory mediators in mouse models and human datasets.
• The result: Loss of TNFR1 diminished MDSC recruitment and tumor growth in immune-competent mice, revealing TNFR1’s role in promoting an immunosuppressive microenvironment and tumor progression.